The Journal of Pathology

Cover image for The Journal of Pathology

June 2012

Volume 227, Issue 2

Pages 131–253, e1–e2

  1. Invited Perspective

    1. Top of page
    2. Invited Perspective
    3. Original Papers
    4. Letters to the Editor
  2. Original Papers

    1. Top of page
    2. Invited Perspective
    3. Original Papers
    4. Letters to the Editor
    1. You have full text access to this OnlineOpen article
      The peritoneal tumour microenvironment of high-grade serous ovarian cancer (pages 136–145)

      D Andrew Leinster, Hagen Kulbe, Gemma Everitt, Richard Thompson, Mauro Perretti, Felicity N. E Gavins, Dianne Cooper, David Gould, Darren P Ennis, Michelle Lockley, Iain A McNeish, Sussan Nourshargh and Frances R Balkwill

      Version of Record online: 18 APR 2012 | DOI: 10.1002/path.4002

    2. You have full text access to this OnlineOpen article
      Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target (pages 146–156)

      Marco Gerlinger, Claudio R Santos, Bradley Spencer-Dene, Pierre Martinez, David Endesfelder, Rebecca A Burrell, Marcus Vetter, Ming Jiang, Rebecca E Saunders, Gavin Kelly, Karl Dykema, Nathalie Rioux-Leclercq, Gordon Stamp, Jean Jacques Patard, James Larkin, Michael Howell and Charles Swanton

      Version of Record online: 18 APR 2012 | DOI: 10.1002/path.4006

      Corrected by:

      Corrigendum: Corrigendum

      Vol. 236, Issue 4, 531, Version of Record online: 27 APR 2015

    3. Intracoronary delivery of DNAzymes targeting human EGR-1 reduces infarct size following myocardial ischaemia reperfusion (pages 157–164)

      Ravinay Bhindi, Roger G Fahmy, Aisling C McMahon, Levon M Khachigian and Harry C Lowe

      Version of Record online: 17 FEB 2012 | DOI: 10.1002/path.2991

    4. Chronic inhibition of endoplasmic reticulum stress and inflammation prevents ischaemia-induced vascular pathology in type II diabetic mice (pages 165–174)

      Ali Amin, Soo-kyoung Choi, Maria Galan, Modar Kassan, Megan Partyka, Philip Kadowitz, Daniel Henrion, Mohamed Trebak, Souad Belmadani and Khalid Matrougui

      Version of Record online: 17 FEB 2012 | DOI: 10.1002/path.3960

    5. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro (pages 175–188)

      Xiao-Ming Meng, Xiao Ru Huang, Jun Xiao, Hai-yong Chen, Xiang Zhong, Arthur CK Chung and Hui Yao Lan

      Version of Record online: 22 FEB 2012 | DOI: 10.1002/path.3976

    6. Central role of lactic acidosis in cancer cell resistance to glucose deprivation-induced cell death (pages 189–199)

      Hao Wu, Zonghui Ding, Danqing Hu, Feifei Sun, Chunyan Dai, Jiansheng Xie and Xun Hu

      Version of Record online: 17 FEB 2012 | DOI: 10.1002/path.3978

    7. BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma (pages 200–208)

      Sara Busacca, Michael Sheaff, Kenneth Arthur, Steven G Gray, Kenneth J O'Byrne, Derek J Richard, Alex Soltermann, Isabelle Opitz, Harvey Pass, D Paul Harkin, Jennifer E Quinn and Dean A Fennell

      Version of Record online: 19 MAR 2012 | DOI: 10.1002/path.3979

    8. Hypothalamic mTOR pathway mediates thyroid hormone-induced hyperphagia in hyperthyroidism (pages 209–222)

      Luis Varela, Noelia Martínez-Sánchez, Rosalía Gallego, María J Vázquez, Juan Roa, Marina Gándara, Erik Schoenmakers, Rubén Nogueiras, Krishna Chatterjee, Manuel Tena-Sempere, Carlos Diéguez and Miguel López

      Version of Record online: 17 FEB 2012 | DOI: 10.1002/path.3984

    9. ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour (pages 223–233)

      Badreddin Edris, Iñigo Espinosa, Thomas Mühlenberg, Amanda Mikels, Cheng-Han Lee, Sonja E Steigen, Shirley Zhu, Kelli D Montgomery, Alexander JF Lazar, Dina Lev, Jonathan A Fletcher, Andrew H Beck, Robert B West, Roel Nusse and Matt van de Rijn

      Version of Record online: 17 FEB 2012 | DOI: 10.1002/path.3986

    10. The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC1 signalling in breast cancer cell migration and dissemination (pages 234–244)

      Lydia M Balz, Kai Bartkowiak, Antje Andreas, Klaus Pantel, Bernd Niggemann, Kurt S Zänker, Burkhard H Brandt and Thomas Dittmar

      Version of Record online: 21 MAR 2012 | DOI: 10.1002/path.3991

      Corrected by:

      Erratum: Erratum

      Vol. 230, Issue 1, e1, Version of Record online: 10 APR 2013

    11. An osteosarcoma zebrafish model implicates Mmp-19 and Ets-1 as well as reduced host immune response in angiogenesis and migration (pages 245–253)

      Alexander B Mohseny, Wei Xiao, Ralph Carvalho, Herman P Spaink, Pancras CW Hogendoorn and Anne-Marie Cleton-Jansen

      Version of Record online: 19 MAR 2012 | DOI: 10.1002/path.3998

  3. Letters to the Editor

    1. Top of page
    2. Invited Perspective
    3. Original Papers
    4. Letters to the Editor
    1. You have free access to this content
      Dosage and tumour suppression (page e1)

      Alice H Berger, Alfred G Knudson and Pier Paolo Pandolfi

      Version of Record online: 25 APR 2012 | DOI: 10.1002/path.4035

    2. You have free access to this content
      Invited response (page e2)

      Hayley Davis and Ian Tomlinson

      Version of Record online: 25 APR 2012 | DOI: 10.1002/path.4038

SEARCH

SEARCH BY CITATION